Motif Neurotech receives FDA Approval to Begin First Clinical Trial of its Therapeutic BCI for Treatment-Resistant Depression

Neurava Awarded $4 Million NIH Blueprint Optimizer Award to Develop SUDEP Risk Stratification Algorithm

PORTENT backs five new technologies to expand access to care 

Next-Generation Restorative Dental Systems FAQs

University Lab Partners Selected by Cimit to Partner in their Project to Support the NIH RADx Initiative

FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test

NIH Collaborates with Diagnostics Manufacturers on Obtaining Authorization of Multiplex Tests

Best Practices Resource for Developing COVID-19 Diagnostic Tests

The Role Rapid Acceleration of Diagnostics Tech Continues to Play in the Covid-19 Pandemic and Next Steps

The RADx Tech Process